share

(S)-Cetirizine Dihydrochloride CAS NO 163837-48-7


Unit Price:

CAS No.:163837-48-7

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

(S)-Cetirizine Dihydrochloride is the pharmacologically active enantiomer of the widely used second-generation antihistamine, cetirizine. This high-purity active pharmaceutical ingredient (API) is critical for developing enantiomerically pure formulations, offering enhanced therapeutic specificity and potentially reduced side-effect profiles. It is primarily required by pharmaceutical manufacturers and research institutions for the production of advanced antihistamine medications and for analytical reference standards.

Application

  • Active Pharmaceutical Ingredient (API): Core component in the manufacture of enantiomerically pure antihistamine tablets, capsules, and oral solutions.
  • Pharmaceutical R&D: Used in preclinical and clinical studies to investigate the specific pharmacokinetics and pharmacodynamics of the (S)-enantiomer.
  • Reference Standard: Serves as a high-purity certified reference material (CRM) for quality control and analytical method development in pharmaceutical laboratories.
  • Formulation Development: Employed in creating novel drug delivery systems, such as sustained-release or fast-dissolving formulations.
  • Generic Drug Manufacturing: Essential for companies producing bioequivalent versions of patented enantiopure cetirizine medications.
  • Metabolite Studies: Used in research to study the metabolic pathways and excretion profiles of the specific enantiomer.

Basic Information

Item Detail
Product Name (S)-Cetirizine Dihydrochloride
CAS No. 163837-48-7
Molecular Formula C21H27Cl3N2O3
Molecular Weight 461.81 g/mol
Synonyms (S)-Cetirizine 2HCl; Levocetirizine Dihydrochloride; (2-{4-[(R)-(4-Chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid dihydrochloride; (S)-[2-[4-[(4-Chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride; R-Cetirizine Dihydrochloride; XYZAL® API (enantiomer); UNII-6U5EA9RT2O
EINECS Contact for details

Quality Control

Our (S)-Cetirizine Dihydrochloride is manufactured under strict quality management systems. Each batch is tested to ensure it meets stringent specifications for identity, purity, and enantiomeric excess, aligning with ICH guidelines. A comprehensive Certificate of Analysis (COA) detailing results for assay, related substances, residual solvents, and chiral purity is provided with every shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption.

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to reference standard
Identification (HPLC) Retention time corresponds to reference
Assay (HPLC) 98.0% - 102.0% (on anhydrous basis)
Enantiomeric Purity (Chiral HPLC) ≥ 99.0%
Related Substances (HPLC) Individual impurity: ≤ 0.5% Total impurities: ≤ 1.5%
Water (KF Titration) ≤ 1.0%
Residue on Ignition ≤ 0.1%
Heavy Metals ≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.